Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin
暂无分享,去创建一个
J. Karlsson | Linda Holmquist Mengelbier | C. Ciornei | A. Naranjo | M. O'sullivan | D. Gisselsson | Cristina D. Ciornei
[1] A. Look,et al. Abnormalities of chromosomes 1 and 11 in Wilms' tumor. , 1985, Cancer genetics and cytogenetics.
[2] H. Punnett,et al. Translocation 10;17 in clear cell sarcoma of the kidney. A first report. , 1989, Cancer genetics and cytogenetics.
[3] B. Lampkin,et al. Chromosome analysis of 31 Wilms' tumors. , 1990, Cancer research.
[4] Y. Kaneko,et al. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. , 1991, Cancer research.
[5] E. Lai,et al. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. , 1996, Genes & development.
[6] E. Batourina,et al. Stromal cells mediate retinoid-dependent functions essential for renal development. , 1999, Development.
[7] J. Squire,et al. Comparative genomic hybridization analysis of clear cell sarcoma of the kidney. , 2000, Medical and pediatric oncology.
[8] N. Breslow,et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. , 2000, The American journal of surgical pathology.
[9] M. Gessler,et al. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. , 2001, The American journal of pathology.
[10] E. Batourina,et al. Vitamin A controls epithelial/mesenchymal interactions through Ret expression , 2001, Nature Genetics.
[11] Frank Speleman,et al. Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. , 2002, Analytical biochemistry.
[12] A I Saeed,et al. TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.
[13] P. Grundy,et al. Genetic and Genetic Expression Analyses of Clear Cell Sarcoma of the Kidney , 2003, Laboratory Investigation.
[14] N. Breslow,et al. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] D. Rakheja,et al. Translocation (10;17)(q22;p13): a recurring translocation in clear cell sarcoma of kidney. , 2004, Cancer genetics and cytogenetics.
[16] E. Cho,et al. Odd-skipped related 1 (Odd 1) is an essential regulator of heart and urogenital development. , 2005, Developmental biology.
[17] M. Rivera,et al. Wilms' tumour: connecting tumorigenesis and organ development in the kidney , 2005, Nature Reviews Cancer.
[18] N. Breslow,et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Roger M. Ilagan,et al. FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons , 2005, Development.
[20] Chiang-Ching Huang,et al. Clear Cell Sarcoma of the Kidney: Up-regulation of Neural Markers with Activation of the Sonic Hedgehog and Akt Pathways , 2005, Clinical Cancer Research.
[21] E. Batourina,et al. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development , 2005, Development.
[22] R. James,et al. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells , 2006, Development.
[23] G. Dressler,et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney , 2006, The EMBO journal.
[24] P. Koty,et al. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. , 2007, Archives of pathology & laboratory medicine.
[25] A. McMahon,et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron , 2007, Development.
[26] A. McMahon,et al. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. , 2008, Developmental biology.
[27] A. McMahon,et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. , 2008, Cell stem cell.
[28] G. Dressler. Advances in early kidney specification, development and patterning , 2009, Development.
[29] A. McMahon,et al. High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population. , 2009, Developmental biology.
[30] J. Karlsson,et al. Tumorigenesis and Neoplastic Progression Deletions of 16 q in Wilms Tumors Localize to Blastemal-Anaplastic Cells and Are Associated with Reduced Expression of the IRXB Renal Tubulogenesis Gene Cluster , 2010 .
[31] M. Little,et al. Defining and redefining the nephron progenitor population , 2011, Pediatric Nephrology.
[32] P. van Eyken,et al. Morphogenesis and molecular mechanisms involved in human kidney development , 2012, Journal of cellular physiology.
[33] J. Karlsson,et al. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney , 2012, The Journal of pathology.
[34] Chiang-Ching Huang,et al. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study , 2012, The Journal of pathology.